Featured ConferenceAmerican Society of Retina Specialists
- REMS Modification Delays Approval of Ravulizumab for NMOSD
- Proptosis Recurrence After Orbital Decompression Risk Factors Identified
- Neuromyelitis Optica Spectrum Disorders Lower Cognitive Performance for Some
- Higher BMI Associated With MOGAD, Not NMO in Racially Diverse Population
- Mild Cognitive Impairment, Dementia Biomarker May Exist in Retinal Microvasculature
- Inebilizumab Treatment for Patients With NMOSD May Not Up COVID-19 Risk
- OCT-A Detects Greater Loss of Retinal Microvasculature in Patients With MS
- Does Vaccination Increase Risk for NMOSD Attacks Among Patients?
- Patients With ALS Have Altered Gaze Patterns When Scanning Facial Expressions
- Ravulizumab Lowers Risk for Relapse in Patients With AQP4+ NMOSD
- The Relationship Between TBI, Mild Cognitive Impairment, and All-Cause Dementia
- Do Patients With MS, NMOSD Have an Elevated Risk for Fractures?
FeaturesMore Neuro Ophthalmology features
Navigating Parental Education in Pediatric Cardiology
Drug Comparison ChartsMORE CLINICAL TOOLS